Surrozen (SRZN) Capital Expenditures (2020 - 2026)
Surrozen's Capital Expenditures came in at $19,000 for Q2 2026, up 5.6% from $18,000 a year earlier but down 84.2% from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Surrozen reported Capital Expenditures of $374,000, up 484.4% year-over-year; for FY2025, it was $280,000, up 976.9% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $26,000 in FY2024 (-93.5%), $398,000 in FY2023 (-45.3%), $728,000 in FY2022 (-42.6%) and $1.27 million in FY2021 (+45.2%).
- The five-year range for quarterly Capital Expenditures is $7,000 (Q1 2024) to $541,000 (Q3 2021).
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 344.4%), and the weakest in Q1 2024 (a decline of 97.8%).
- Business Quant data shows SRZN's Capital Expenditures at $120,000 (Q1 2026), $211,000 (Q4 2025) and $24,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Surrozen | 389.19 Mn | 9.67 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 339,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 400,000.00 |
| Dec 31, 2022 | 224,000.00 |
| Sep 30, 2022 | 154,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 412,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 593,000.00 |
| Jun 30, 2021 | 180,000.00 |
| Mar 31, 2021 | 380,000.00 |
| Dec 31, 2020 | 727,000.00 |
API Access
Surrozen Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();